# Clinical Study of Granulocyte Infusion for Advanced Cancer

> **NCT04124666** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Cancer

## Interventions

- **BIOLOGICAL:** Granulocytes

## Key facts

- **NCT ID:** NCT04124666
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124666, "Clinical Study of Granulocyte Infusion for Advanced Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04124666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*